Alfred Siegfried

Bachelor of Medicine and Bachelor of Science,  The Johns Hopkins Hospital 

Location: Africa

Consulting Services

Sales and Marketing Admin and Customer Support Hospital-Pharmacy-Insurance Scientific Writing

Areas Of Interest

Shoulders Scan, X-Ray Micro-CAT Charadriiformes Information System, Laboratory Cancer, Intestinal Roles, Woman's Genomes, Chloroplast DNA Denaturation Cross Linking and Immunoprecipitation Followed by Deep Sequencing Zellweger-Like Syndrome Adjustments, Occlusal D40TA CTLA8 Drug Mules KCNC2 Potassium Channel Execution, Gas Chamber Cyclin Dependent Kinase Inhibitor p57 p19, Phosphoprotein Intra-Arterial Infusions Vanco Azupharma Bombs Ligament, Flaval Tocopherol, d-alpha Bone Marrow Examination Receptor-Associated Coactivator 3 Aides, Homemaker-Home Health NADP Succinate-Semialadehyde Reductase Shotguns Manipulation, Psychologic Cooperation, Intersectoral Adenosine-5'-N-ethyluronamide Bacterial Endocarditis UCB 6215 Vitamin B Deficiency Design, Hospital Depression, Unipolar Biologic Factor Tertiary Protein Structures

Professional Narrative

Dr. Alfred Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Harvard Med 1996
Senior Director, Mayo Clinic 1998

Education

Master of Science in physician assistant, Perelman School of Medicine 2012
Bachelor of science in nursing, Weill Medical College 2018

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :